Experience of using telmisartan, atorvastatin and ursodeoxycholic acid in patients with arterial hypertension in combination with non-alcoholic fatty liver disease
A number of studies have now been conducted confirming the relationship between arterial hypertension (AH) and nonalcoholic fatty liver disease (NAFLD). It has been proved that the presence of AH increases or provokes the development of NAFLD. A study of telmisartan effectiveness in combination with...
Main Authors: | O. A. Efremova, P. E. Chernobay, E. P. Pogurelskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Siberian Branch Publishing House
2021-10-01
|
Series: | Сибирский научный медицинский журнал |
Subjects: | |
Online Access: | https://sibmed.elpub.ru/jour/article/view/666 |
Similar Items
-
Interaction of telmisartan and related sartans with the programmed cell death-ligand 1 (PD-L1) protein dimer: a molecular docking analysis
by: Gérard Vergoten, et al.
Published: (2023-12-01) -
Effect of Combination Therapy with Atorvastatin and Ursodeoxycholic Acid on the Course of Ischemic Heart Disease with Co-Existent Non-Alcoholic Fatty Liver Disease and Obesity
by: Nataliya Karpyshyn
Published: (2016-12-01) -
A Fast and Validated Reversed-Phase HPLC Method for Simultaneous Determination of Simvastatin, Atorvastatin, Telmisartan and Irbesartan in Bulk Drugs and Tablet Formulations
by: Hassan A. Alhazmi, et al.
Published: (2017-12-01) -
Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients Efectos de telmisartan vs olmesartan sobre parámetros antropométricos, resistencia a la insulina y adipocitoquinas en pacientes hipertensos obesos
by: D. A. de Luis, et al.
Published: (2010-04-01) -
Immune pleiotropic effect of telmisartan in arterial hypertension
by: N. M. Agarkov, et al.
Published: (2022-07-01)